Iron-Doped Hydroxyapatite Nanoparticles for Magnetic Guided siRNA Delivery
International Journal of Molecular Sciences · 09.08.2025 · 26 (16) · 7712
DOI: 10.3390/ijms26167712 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.08.2025. Verfasst von Hina Inam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Science, Technology and Sustainability for Ceramics (ISSMC), National Research Council of Italy (CNR), 48018 Faenza, Italy. Hauptthemen laut MEDLINE: RNA, Small Interfering, Durapatite, Iron, Nanoparticles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, European Union, National Center for Gene Therapy and Drugs based on RNA Technology.
Abstract (Originalsprache)
Small interfering RNAs (siRNAs) are particularly attractive among the frontier drugs due to their high specificity of action, activity on disease-inducing genes, and small molecular weight, thus being one of the most studied agents for gene therapy. However, siRNAs are prone to fast enzymatic degradation in the bloodstream, as well as other limitations that challenge their clinical translation. Nanoparticle (NP) delivery of siRNA has been proposed as a potential solution, overcoming their intrinsic limitations. In this regard, the siRNA delivery by magnetic nanoparticles is of particular interest because, being susceptible to external magnetic fields, it may be guided remotely, maximizing transfection efficiency and minimizing side effects. In addition, magnetic NPs would also allow a theranostic combination of drug delivery, magnetic resonance imaging, and hyperthermia. In this work we have studied the uptake of a model therapeutic siRNA by iron-doped hydroxyapatite nanoparticles (FeHA NPs), which are known to have excellent biocompatibility and magnetic susceptibility. We discovered that FeHA NPs stabilized by citrate (Cit-FeHA NPs) uptake siRNA by adsorption quickly and with high efficiency (ca. 90%) without altering nanoparticles physicochemical properties or colloidal stability. SiRNA-loaded Cit-FeHA NPs are able to slowly release their payload, with a sustained release of 45 days without siRNA degradation. Our work is therefore the preliminary validation of the suitability of FeHA NPs for magnetically guided delivery of therapeutic siRNAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Science, Technology and Sustainability for Ceramics (ISSMC), National Research Council of Italy (CNR), 48018 Faenza, Italy.
- Department of Material Science and Technology, University of Parma, 43121 Parma, Italy.
- Dipartimento di Chimica e Chimica Industriale, Università Degli Studi di Genova, 16146 Genova, Italy.
- Institute of Materials for Electronics and Magnetism (IMEM), National Research Council of Italy (CNR), 43124 Parma, Italy.
ORCID-Profile: Lorenzo Degli Esposti, Francesca Casoli, Simone Sprio
Förderung
- European Commission
- European Union
- National Center for Gene Therapy and Drugs based on RNA Technology
Zitieren
APA
Inam, H., Degli Esposti, L., Pupilli, F., Tavoni, M., Casoli, F., Sprio, S., & Tampieri, A. (2025). Iron-Doped Hydroxyapatite Nanoparticles for Magnetic Guided siRNA Delivery. International Journal of Molecular Sciences, 26(16), 7712. https://doi.org/10.3390/ijms26167712
Vancouver
Inam H, Degli Esposti L, Pupilli F, Tavoni M, Casoli F, Sprio S, et al. Iron-Doped Hydroxyapatite Nanoparticles for Magnetic Guided siRNA Delivery. International Journal of Molecular Sciences. 2025;26(16):7712. doi:10.3390/ijms26167712
BibTeX
@article{Inam2025,
author = {Inam, Hina and Degli Esposti, Lorenzo and Pupilli, Federico and Tavoni, Marta and Casoli, Francesca and Sprio, Simone and Tampieri, Anna},
title = {Iron-Doped Hydroxyapatite Nanoparticles for Magnetic Guided siRNA Delivery},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {16},
pages = {7712},
doi = {10.3390/ijms26167712}
}
EUVIMED